2011
DOI: 10.1016/j.jcms.2010.05.009
|View full text |Cite
|
Sign up to set email alerts
|

Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: Not just a sporadic coincidence – a multi-centre study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
65
1
8

Year Published

2011
2011
2020
2020

Publication Types

Select...
6
3
1

Relationship

2
8

Authors

Journals

citations
Cited by 120 publications
(77 citation statements)
references
References 53 publications
3
65
1
8
Order By: Relevance
“…These findings are compatible with those of previously reported studies. 28,29 However, the positive association between the oral administration of BPs and a positive surgical outcome disagrees somewhat with previous reports based on smaller samples. 17 Surgical outcome also appears to be influenced by corticosteroid therapy.…”
Section: Discussioncontrasting
confidence: 85%
“…These findings are compatible with those of previously reported studies. 28,29 However, the positive association between the oral administration of BPs and a positive surgical outcome disagrees somewhat with previous reports based on smaller samples. 17 Surgical outcome also appears to be influenced by corticosteroid therapy.…”
Section: Discussioncontrasting
confidence: 85%
“…Less uniform is the percentage of BRONJ among non-cancer, osteoporotic patients within whole samples also comprising cancer patients: in a multi-center study, a BRONJ frequency of 7.1% in patients treated with oral BP therapy [41] was reported; a frequency of 8.9% of BRONJ after per os BP administration was observed in two Israeli medical centers; and, of all the BRONJ patients in other case series reported in the literature, the percentage of orally-administered bisphosphonate-induced ONJ ranges from 2.5% to 27.3% [58]. In the absence of reliable statistics indicating the number of patients exposed to BPs, it is still not easy to establish the real risk of developing BRONJ for non-cancer patients, also due to the large number of supposed and still unascertained risk factors.…”
Section: European Journal Of Internal Medicine 24 (2013) 784-790mentioning
confidence: 99%
“…4,5,8,9 Osteonecrosis of the jaw has also been reported as a result of prolonged bisphosphonate therapy. 10 We present a case study of a patient who had alendronate-associated bilateral subtrochanteric femoral stress fractures that went untreated until the patient suffered a complete fracture in the subtrochanteric region of the right femur. A retrospective review of previous emergency department (ED) visits and imaging demonstrate the characteristic presentation of femoral stress fractures associated with bisphosphonate use.…”
Section: -3mentioning
confidence: 99%